• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表转录组医学的曙光。

Dawn of Epitranscriptomic Medicine.

机构信息

Institute of Cardiovascular Regeneration, Center of Molecular Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany (A.G., K.S.).

Department of Cardiology, Center of Internal Medicine, Goethe University Frankfurt, Germany (A.G., K.S.).

出版信息

Circ Genom Precis Med. 2018 Sep;11(9):e001927. doi: 10.1161/CIRCGEN.118.001927.

DOI:10.1161/CIRCGEN.118.001927
PMID:30354331
Abstract

Medicine is at the crossroads of expanding disciplines. Prompt adaptation of medicine to each rapidly advancing research field, bridging bench to bedside, is a key step toward health improvement. Cardiovascular disease still ranks first among the mortality causes in the Western world, indicating a poor adaptation rate of cardiovascular medicine, albeit the gigantic scientific breakthroughs of this century. This urges the cardiovascular research field to explore novel concepts with promising prognostic and therapeutic potential. This review attempts to introduce the newly emerging field of epitranscriptome (or else known as RNA epigenetics) to cardiovascular researchers and clinicians summarizing its applications on health and disease. The traditionally perceived, intermediate carrier of genetic information or as contemporary revised as, occasionally, even the final product of gene expression, RNA, is dynamically subjected to >140 different kinds of chemical modifications determining its fate, which may profoundly impact the cellular responses and thus both health and disease course. Which are the most prevalent types of these RNA modifications, how are they catalyzed, how are they regulated, which role may they play in health and disease, and which are the implications for the cardiovascular medicine are few important questions that are discussed in the present review.

摘要

医学正处于多个学科交叉的十字路口。医学需要迅速适应每个快速发展的研究领域,实现从实验室到临床的转化,这是改善健康的关键一步。心血管疾病仍然是西方世界死亡原因之首,这表明尽管本世纪取得了巨大的科学突破,心血管医学的适应速度仍然较慢。这促使心血管研究领域探索具有潜在预测和治疗价值的新概念。本文试图向心血管研究人员和临床医生介绍新兴的表观转录组学(也称为 RNA 表观遗传学)领域,总结其在健康和疾病中的应用。传统上被认为是遗传信息的中间载体,或者如当代所修正的,偶尔甚至是基因表达的最终产物的 RNA,会受到 140 多种不同类型的化学修饰,这些修饰决定了 RNA 的命运,可能会深刻影响细胞反应,从而影响健康和疾病进程。这些 RNA 修饰最常见的类型有哪些?它们是如何被催化的?它们是如何被调控的?它们在健康和疾病中可能扮演什么角色?这些问题对于心血管医学有哪些影响?这些都是本文讨论的重要问题。

相似文献

1
Dawn of Epitranscriptomic Medicine.表转录组医学的曙光。
Circ Genom Precis Med. 2018 Sep;11(9):e001927. doi: 10.1161/CIRCGEN.118.001927.
2
Understanding RNA modifications: the promises and technological bottlenecks of the 'epitranscriptome'.解读RNA修饰:“表观转录组学”的前景与技术瓶颈
Open Biol. 2017 May;7(5). doi: 10.1098/rsob.170077.
3
Epitranscriptomics of cardiovascular diseases (Review).心血管疾病的表观转录组学(综述)。
Int J Mol Med. 2022 Jan;49(1). doi: 10.3892/ijmm.2021.5064. Epub 2021 Nov 18.
4
[Lights and shadows of combined epigenomic and transcriptomic profiling to identify novel diagnostic, prognostic or therapeutic targets for cardiovascular diseases.].[联合表观基因组学和转录组学分析以确定心血管疾病新的诊断、预后或治疗靶点的利弊]
G Ital Med Lav Ergon. 2019 Dec;41(4):328-332.
5
A Census and Categorization Method of Epitranscriptomic Marks.转录组修饰的普查与分类方法。
Int J Mol Sci. 2020 Jun 30;21(13):4684. doi: 10.3390/ijms21134684.
6
Epitranscriptome sequencing technologies: decoding RNA modifications.转录组测序技术:解码 RNA 修饰。
Nat Methods. 2016 Dec 29;14(1):23-31. doi: 10.1038/nmeth.4110.
7
Epitranscriptomic Code and Its Alterations in Human Disease.转录组码及其在人类疾病中的改变。
Trends Mol Med. 2018 Oct;24(10):886-903. doi: 10.1016/j.molmed.2018.07.010. Epub 2018 Aug 14.
8
Statistical Methods for Transcriptome-Wide Analysis of RNA Methylation by Bisulfite Sequencing.用于通过亚硫酸氢盐测序进行全转录组RNA甲基化分析的统计方法
Methods Mol Biol. 2017;1562:155-167. doi: 10.1007/978-1-4939-6807-7_11.
9
Overview of high throughput sequencing technologies to elucidate molecular pathways in cardiovascular diseases.高通量测序技术概述,阐明心血管疾病中的分子途径。
Circ Res. 2013 Jun 7;112(12):1613-23. doi: 10.1161/CIRCRESAHA.113.300939.
10
Next-Generation Sequencing in Cardiovascular Disease: Present Clinical Applications and the Horizon of Precision Medicine.心血管疾病中的下一代测序:当前临床应用与精准医学的前景
Circulation. 2017 Jan 31;135(5):406-409. doi: 10.1161/CIRCULATIONAHA.116.024258.

引用本文的文献

1
Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease.环境毒素诱导的表观转录组改变:对RNA修饰和疾病的影响。
Genes Environ. 2025 Aug 4;47(1):14. doi: 10.1186/s41021-025-00337-9.
2
Clinician's Guide to Epitranscriptomics: An Example of N-Methyladenosine (mA) RNA Modification and Cancer.表观转录组学临床医生指南:以N-甲基腺苷(m⁶A)RNA修饰与癌症为例
Life (Basel). 2024 Sep 25;14(10):1230. doi: 10.3390/life14101230.
3
Current Understanding of piRNA in Cardiovascular Diseases.当前对心血管疾病中piRNA的认识。
Front Mol Med. 2022 Jan 12;1:791931. doi: 10.3389/fmmed.2021.791931. eCollection 2021.
4
The Current Therapeutic Role of Chromatin Remodeling for the Prognosis and Treatment of Heart Failure.染色质重塑在心力衰竭预后和治疗中的当前治疗作用
Biomedicines. 2023 Feb 16;11(2):579. doi: 10.3390/biomedicines11020579.
5
RNA Editing Therapeutics: Advances, Challenges and Perspectives on Combating Heart Disease.RNA 编辑治疗学:治疗心脏病的进展、挑战与展望。
Cardiovasc Drugs Ther. 2023 Apr;37(2):401-411. doi: 10.1007/s10557-022-07391-3. Epub 2022 Oct 14.
6
(Epi)transcriptomics in cardiovascular and neurological complications of COVID-19.新型冠状病毒肺炎心血管和神经并发症中的(表观)转录组学
J Mol Cell Cardiol Plus. 2022 Sep;1:100013. doi: 10.1016/j.jmccpl.2022.100013. Epub 2022 Jul 28.
7
RNA-Binding Proteins: Emerging Therapeutics for Vascular Dysfunction.RNA 结合蛋白:血管功能障碍的新兴治疗靶点。
Cells. 2022 Aug 11;11(16):2494. doi: 10.3390/cells11162494.
8
Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases.RNA修饰N6-甲基腺苷和腺苷到肌苷在心血管疾病中的新作用。
Mol Ther Nucleic Acids. 2022 Jul 20;29:426-461. doi: 10.1016/j.omtn.2022.07.018. eCollection 2022 Sep 13.
9
Reduction of A-to-I RNA editing in the failing human heart regulates formation of circular RNAs.衰竭人类心脏中的 A-to-I RNA 编辑减少调控环状 RNA 的形成。
Basic Res Cardiol. 2022 Jun 23;117(1):32. doi: 10.1007/s00395-022-00940-9.
10
Direct RNA Sequencing Reveals SARS-CoV-2 m6A Sites and Possible Differential DRACH Motif Methylation among Variants.直接 RNA 测序揭示 SARS-CoV-2 m6A 位点和变体中可能存在的不同 DRACH 基序甲基化。
Viruses. 2021 Oct 20;13(11):2108. doi: 10.3390/v13112108.